SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $50 | $38 | $41 | $56 |
| - Cash | $3 | $4 | $7 | $5 |
| + Debt | $0 | $1 | $1 | $3 |
| Enterprise Value | $47 | $35 | $36 | $54 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -41.85 | -40.48 | -95.99 | -90.33 |
| % Growth | -3.4% | 57.8% | -6.3% | – |
| Operating Cash Flow | -$4 | -$5 | -$7 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$5 | -$7 | -$7 |